Brief: Regenxbio Announces FDA Acceptance And Priority Review Of BLA For Rgx-121 For Mps Ii
13/05/2025 12:40
May 13 (Reuters) - Regenxbio Inc RGNX.O: REGENXBIO ANNOUNCES FDA ACCEPTANCE AND PRIORITY REVIEW OF THE BLA FOR RGX-121 FOR MPS II REGENXBIO INC - FDA GRANTS PRIORITY REVIEW FOR RGX-121, ACTION DATE NOV 9, 2025 Source text: ID:nPn4lkvMxa Further company coverage: RGNX.O ((Reuters.Briefs@thomsonreuters.com;))